In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Athanasios John Manolis
Speaker
Athanasios John Manolis
Athanasios John Manolis Athanasios John Manolis

Asklepieion Voulas General Hospital, Athens (Greece)

Specialities : Coronary Artery Disease Chronic , Hypertension, Chronic Heart Failure

He is Past President of the WG Hypertension and Heart of the ESC, Council member of the ESH, Past President of the Hellenic Society of Hypertension and Treasurer of the Hellenic Society of Cardiology. He has been involved in the Task Force of the ESC guidelines and the Joint ESC/ESH Guidelines for Hypertension. He has published more than 250 original papers in peer reviewed Journals, and 30 chapter in books. He is Associate Editor of the European Journal of Internal Medicine, and reviewer in many Journals

19 presentations from this speaker

Bridging the gap in the management of stable angina patients - Questions and answers, closing remarks

Event : ESC Congress 2019

  • Session : Bridging the gap in the management of stable angina patients
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Menarini Group

Facts vs. "Alternative facts" about Vasodilating beta blockers

Event : ESC Congress 2019

  • Session : Beta blockers are not a homogeneous class
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Menarini Group

Introduction

Event : ESC Congress 2019

  • Session : Bridging the gap in the management of stable angina patients
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Menarini Group

1, the real essence in stable angina: the patient’s experience.

Event : ESC Congress 2018

  • Session : The number 3 – Perfection? The ideal synthesis even in stable angina management
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Menarini Group

Fatal attraction: hypertension and atrial fibrillation - Current knowledge

Event : ESC Congress 2018

  • Session : Hypertension and Atrial Fibrillation
  • Speaker : AJ Manolis (Voula, Athens,GR)

Urate lowering therapy adherence in general practice.

Event : ESC Congress 2018

  • Session : Hyperuricemia : a key player in multisystemic diseases
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Menarini Group

Dilemmas in managing atrial fibrillation in hypertension

Event : ESC Congress 2017

  • Session : Arrhythmias in hypertension
  • Speaker : AJ Manolis (Voula, Athens,GR)

How our approach could meet patients' needs.

Event : ESC Congress 2017

  • Session : QoL in stable angina: is it a questionable or a long-standing point of view?
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by The Menarini Group

A novel tailored algorithm for Stable Coronary Artery Disease (SCAD) management.

Event : ESC Congress 2016

  • Session : New approaches to Stable Coronary Artery Disease (SCAD): broadening the management paradigm
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.

Hyperuricaemia and CV outcomes.

Event : ESC Congress 2016

  • Session : Heart under siege: the dark side of hyperuricaemia
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.

Open discussion and closing remarks - New approaches to Stable Coronary Artery Disease (SCAD): broadening the management paradigm.

Event : ESC Congress 2016

  • Session : New approaches to Stable Coronary Artery Disease (SCAD): broadening the management paradigm
  • Speaker : AJ Camm (London,GB), J Lopez-Sendon (Madrid,ES), G Ambrosio (Perugia,IT), AJ Manolis (Voula, Athens,GR), R Dechend (Berlin,DE)
  • Sponsored by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.

Discussion - Hyperuricemia: new crimes for an old foe.

Event : ESC Congress 2015

  • Session : Hyperuricemia: new crimes for an old foe
  • Speaker : AJ Manolis (Voula, Athens,GR), A Cicero (Bologna,IT), C Borghi (Bologna,IT)
  • Sponsored by The Menarini Group

Introduction - Hyperuricemia: new crimes for an old foe.

Event : ESC Congress 2015

  • Session : Hyperuricemia: new crimes for an old foe
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by The Menarini Group

Pivotal aspects of pathophysiology.

Event : ESC Congress 2015

  • Session : Hyperuricemia: new crimes for an old foe
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by The Menarini Group

Atrial fibrillation.

Event : ESC Congress 2014

  • Session : Hypertension in the patient at high cardiovascular risk
  • Speaker : AJ Manolis (Voula, Athens,GR)

Pro/Contra: hypertension control in Belgium and Luxembourg: please improve!

Event : ESC Congress 2014

  • Session : Hypertension control around the world: can we do better?
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Recordati / Zambon

Wordlwide trends in hypertension diagnosis, treatment and control: where do we stand now?

Event : ESC Congress 2014

  • Session : Hypertension control around the world: can we do better?
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Recordati / Zambon

ACE-inhibitors pharmacological effects: just a matter of mmHg?

Event : ESC Congress 2013

  • Session : Ace-inhibitors and cardioprotection: open issues and future solutions
  • Speaker : AJ Manolis (Voula, Athens,GR)
  • Sponsored by Menarini Group

Panel.

Event : ESC Congress 2013

  • Session : The cardiovascular system and obstructive sleep apnea syndrome
  • Speaker : R Cifkova (Prague,CZ), I Fietze (Berlin,DE), G Parati (Milano,IT), AJ Manolis (Voula, Athens,GR), K Narkiewicz (Gdansk,PL)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are